Home HIV	FAQ My Amedeo About	Flying Publisher
	Amedeo Prize 2008 The 21 Finalists

Parkinson's Disease

Free Subscription Articles published in J Neurochem Retrieve available abstracts of 45 articles: HTML format

Single Articles

April 2008
1. FANTIN M , Auberson YP, Morari M
   Differential effect of NR2A and NR2B subunit selective NMDA receptor antagonists on striato-pallidal neurons: relationship to motor response in the 6-hydroxydopamine model of parkinsonism.
   J Neurochem. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
2. CHATURVEDI RK , Flint Beal M
   PPAR: A therapeutic target in Parkinson's disease.
   J Neurochem. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
3. MILLS RD , Sim CH, Mok SS, Mulhern TD, et al
   Biochemical aspects of the neuroprotective mechanism of PTEN-induced kinase-1 (PINK1).
   J Neurochem. 2008;105:18-33.
   PubMed     Related articles    Abstract available
   
   
   March 2008
4. MIYAZAKI S , Yanagida T, Nunome K, Ishikawa S, et al
   DJ-1-binding compounds prevent oxidative stress-induced cell death and movement defect in Parkinson's disease model rats.
   J Neurochem. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
5. LIU F , Nguyen JL, Hulleman JD, Li L, et al
   Mechanisms of DJ-1 neuroprotection in a cellular model of Parkinson's disease.
   J Neurochem. 2008;.
   PubMed     Related articles    Abstract available
   
   
   February 2008
6. THOMAS T , Timmer M, Cesnulevicius K, Hitti E, et al
   MAPKAP kinase 2-deficiency prevents neurons from cell death by reducing neuroinflammation - relevance in a mouse model of Parkinson's disease.
   J Neurochem. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
7. DIETZ GP , Stockhausen KV, Dietz B, Falkenburger BH, et al
   Membrane-permeable Bcl-xL prevents MPTP-induced dopaminergic neuronal loss in the substantia nigra.
   J Neurochem. 2008;104:757-65.
   PubMed     Related articles    Abstract available
   
   
   January 2008
8. BAR-ON P , Crews L, Koob AO, Mizuno H, et al
   Statins reduce neuronal alpha-synuclein aggregation in in vitro models of Parkinson's disease.
   J Neurochem. 2008;.
   PubMed     Related articles    Abstract available
   
   
   December 2007
9. NAGEL F , Falkenburger BH, Tonges L, Kowsky S, et al
   Tat-Hsp70 protects dopaminergic neurons in midbrain cultures and in the substantia nigra in models of Parkinson's disease.
   J Neurochem. 2007;.
   PubMed     Related articles    Abstract available
   
   
   
10. CHASSAIN C , Bielicki G, Durand E, Lolignier S, et al
    Metabolic changes detected by proton magnetic resonance spectroscopy in vivo and in vitro in a murin model of Parkinson's disease, the MPTP-intoxicated mouse.
    J Neurochem. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
11. LAVOIE MJ , Cortese GP, Ostaszewski BL, Schlossmacher MG, et al
    The effects of oxidative stress on parkin and other E3 ligases.
    J Neurochem. 2007;103:2354-68.
    PubMed     Related articles    Abstract available
    
    
    November 2007
12. SAMANTARAY S , Knaryan VH, Butler JT, Ray SK, et al
    Spinal cord degeneration in C57BL/6N mice following induction of experimental parkinsonism with MPTP.
    J Neurochem. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
13. REYNOLDS AD , Glanzer JG, Kadiu I, Ricardo-Dukelow M, et al
    Nitrated alpha-synuclein-activated microglial profiling for Parkinson's disease.
    J Neurochem. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
14. CANEDA-FERRON B , De Girolamo LA, Costa T, Beck KE, et al
    Assessment of the direct and indirect effects of MPP(+) and dopamine on the human proteasome: implications for Parkinson's Disease aetiology.
    J Neurochem. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
15. CHEN MK , Kuwabara H, Zhou Y, Adams RJ, et al
    VMAT2 and dopamine neuron loss in a primate model of Parkinson's disease.
    J Neurochem. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
16. BURKE RE
    PROGRAMMED CELL DEATH AND NEW DISCOVERIES IN THE GENETICS OF PARKINSONISM.
    J Neurochem. 2007;.
    PubMed     Related articles    Abstract available
    
    
    October 2007
17. CLEREN C , Yang L, Lorenzo B, Calingasan NY, et al
    Therapeutic effects of Coenzyme Q(10) (CoQ(10)) and reduced CoQ(10) in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine model of Parkinsonism.
    J Neurochem. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
18. REN Y , Feng J
    Rotenone selectively kills serotonergic neurons through a microtubule-dependent mechanism.
    J Neurochem. 2007;103:303-11.
    PubMed     Related articles    Abstract available
    
    
    
19. BIBL M , Esselmann H, Mollenhauer B, Weniger G, et al
    Blood-based neurochemical diagnosis of vascular dementia: a pilot study.
    J Neurochem. 2007;103:467-74.
    PubMed     Related articles    Abstract available
    
    
    September 2007
20. ANASTASIA A , de Erausquin GA, Wojnacki J, Masco DH, et al
    Protection of dopaminergic neurons by electroconvulsive shock in an animal model of Parkinson's disease.
    J Neurochem. 2007;.
    PubMed     Related articles    Abstract available
    
    
    August 2007
21. BYCHKOV E , Ahmed MR, Dalby KN, Gurevich EV, et al
    Dopamine depletion and subsequent treatment with L-DOPA, but not the long-lived dopamine agonist pergolide, enhances activity of the Akt pathway in the rat striatum.
    J Neurochem. 2007;102:699-711.
    PubMed     Related articles    Abstract available
    
    
    
22. ZAFAR KS , Inayat-Hussain SH, Ross D
    A comparative study of proteasomal inhibition and apoptosis induced in N27 mesencephalic cells by dopamine and MG132.
    J Neurochem. 2007;102:913-21.
    PubMed     Related articles    Abstract available
    
    
    July 2007
23. LI X , Tan YC, Poulose S, Olanow CW, et al
    Leucine-rich repeat kinase 2 (LRRK2)/PARK8 possesses GTPase activity that is altered in familial Parkinson's disease R1441C/G mutants.
    J Neurochem. 2007;.
    PubMed     Related articles    Abstract available
    
    
    June 2007
24. HUOT P , Parent A
    Dopaminergic neurons intrinsic to the striatum.
    J Neurochem. 2007;101:1441-7.
    PubMed     Related articles    Abstract available
    
    
    May 2007
25. PAPACHRONI KK , Ninkina N, Papapanagiotou A, Hadjigeorgiou GM, et al
    Autoantibodies to alpha-synuclein in inherited Parkinson's disease.
    J Neurochem. 2007;101:749-56.
    PubMed     Related articles    Abstract available
    
    
    April 2007
26. MICHEL PP , Alvarez-Fischer D, Guerreiro S, Hild A, et al
    Role of activity-dependent mechanisms in the control of dopaminergic neuron survival.
    J Neurochem. 2007;101:289-97.
    PubMed     Related articles    Abstract available
    
    
    March 2007
27. GREGGIO E , Lewis PA, van der Brug MP, Ahmad R, et al
    Mutations in LRRK2/dardarin associated with Parkinson disease are more toxic than equivalent mutations in the homologous kinase LRRK1.
    J Neurochem. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
28. MELA F , Marti M, Dekundy A, Danysz W, et al
    Antagonism of metabotropic glutamate receptor type 5 attenuates l-DOPA-induced dyskinesia and its molecular and neurochemical correlates in a rat model of Parkinson's disease.
    J Neurochem. 2007;.
    PubMed     Related articles    Abstract available
    
    
    February 2007
29. BORTA A , Hoglinger GU
    Dopamine and adult neurogenesis.
    J Neurochem. 2007;100:587-95.
    PubMed     Related articles    Abstract available
    
    
    January 2007
30. SHERER TB , Richardson JR, Testa CM, Seo BB, et al
    Mechanism of toxicity of pesticides acting at complex I: relevance to environmental etiologies of Parkinson's disease.
    J Neurochem. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
31. THOMAS MP , Chartrand K, Reynolds A, Vitvitsky V, et al
    Ion channel blockade attenuates aggregated alpha synuclein induction of microglial reactive oxygen species: relevance for the pathogenesis of Parkinson's disease.
    J Neurochem. 2007;100:503-19.
    PubMed     Related articles    Abstract available
    
    
    December 2006
32. BRETAUD S , Allen C, Ingham PW, Bandmann O, et al
    p53-dependent neuronal cell death in a DJ-1-deficient zebrafish model of Parkinson's disease.
    J Neurochem. 2006;.
    PubMed     Related articles    Abstract available
    
    
    November 2006
33. HIGASHI S , Moore DJ, Colebrooke RE, Biskup S, et al
    Expression and localization of Parkinson's disease-associated leucine-rich repeat kinase 2 in the mouse brain.
    J Neurochem. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
34. TEHRANIAN R , Montoya SE, Van Laar AD, Hastings TG, et al
    Alpha-synuclein inhibits aromatic amino acid decarboxylase activity in dopaminergic cells.
    J Neurochem. 2006;99:1188-96.
    PubMed     Related articles    Abstract available
    
    
    October 2006
35. HOLTZ WA , Turetzky JM, Jong YJ, O'malley KL, et al
    Oxidative stress-triggered unfolded protein response is upstream of intrinsic cell death evoked by parkinsonian mimetics.
    J Neurochem. 2006;99:54-69.
    PubMed     Related articles    Abstract available
    
    
    
36. HIRATA Y , Meguro T, Kiuchi K
    Differential effect of nerve growth factor on dopaminergic neurotoxin-induced apoptosis.
    J Neurochem. 2006;99:416-25.
    PubMed     Related articles    Abstract available
    
    
    August 2006
37. RODGERS KJ , Hume PM, Morris JG, Dean RT, et al
    Evidence for L-dopa incorporation into cell proteins in patients treated with levodopa.
    J Neurochem. 2006;98:1061-7.
    PubMed     Related articles    Abstract available
    
    
    July 2006
38. ABELIOVICH A , Beal MF
    Parkinsonism genes: culprits and clues.
    J Neurochem. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
39. YAMASHITA H , Nakamura T, Takahashi T, Nagano Y, et al
    Embryonic stem cell-derived neuron models of Parkinson's disease exhibit delayed neuronal death.
    J Neurochem. 2006;98:45-56.
    PubMed     Related articles    Abstract available
    
    
    
40. MUQIT MM , Abou-Sleiman PM, Saurin AT, Harvey K, et al
    Altered cleavage and localization of PINK1 to aggresomes in the presence of proteasomal stress.
    J Neurochem. 2006;98:156-69.
    PubMed     Related articles    Abstract available
    
    
    June 2006
41. BENMOYAL-SEGAL L , Soreq H
    Gene-environment interactions in sporadic Parkinson's disease.
    J Neurochem. 2006;97:1740-55.
    PubMed     Related articles    Abstract available
    
    
    May 2006
42. FURUKAWA K , Matsuzaki-Kobayashi M, Hasegawa T, Kikuchi A, et al
    Plasma membrane ion permeability induced by mutant alpha-synuclein contributes to the degeneration of neural cells.
    J Neurochem. 2006;97:1071-7.
    PubMed     Related articles    Abstract available
    
    
    
43. CASAREJOS MJ , Menendez J, Solano RM, Rodriguez-Navarro JA, et al
    Susceptibility to rotenone is increased in neurons from parkin null mice and is reduced by minocycline.
    J Neurochem. 2006;97:934-46.
    PubMed     Related articles    Abstract available
    
    
    April 2006
44. OUYANG M , Shen X
    Critical role of ASK1 in the 6-hydroxydopamine-induced apoptosis in human neuroblastoma SH-SY5Y cells.
    J Neurochem. 2006;97:234-44.
    PubMed     Related articles    Abstract available
    
    
    March 2006
45. MEUER K , Pitzer C, Teismann P, Kruger C, et al
    Granulocyte-colony stimulating factor is neuroprotective in a model of Parkinson's disease.
    J Neurochem. 2006;.
    PubMed     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: